NDC 60219-1656-01 - Sucralfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60219-1656
- Requested NDC
- 60219-1656-01
- Package NDCs from labels
- 60219-1656-1, 60219-1656-5, 60219-1656-01
- Manufacturer
- Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited
- Effective date
- 2024-03-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sucralfate Tablets, USP | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 2024-03-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60219-1656-1 | Sucralfate | 100 in 1 BOTTLE | TABLET | 100 | 1 | |
| 60219-1656-5 | Sucralfate | 500 in 1 BOTTLE | TABLET | 500 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60219-1656 | SUCRALFATE TABLET [AMNEAL PHARMACEUTICALS NY LLC] | 1 | Current NDC, 2 package rows | 20240303_b2e07ac7-4a8a-4b68-bb65-167d1aa86883.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60219-1656-1 | EA - Each | 60219-1656 | 899bd11e-befa-4fd1-8566-12d1dfe09db1 | 1 | 2024-09-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sucralfate | SUCRALFATE | AvKARE | 0909acc5-c746-17fb-e063-6394a90a677f | 2026-01-19 | Adverse reactions | ANDA215576 314234 XX73205DH5 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Sucralfate oral suspension | SUCRALFATE | Glenmark Pharmaceuticals Inc., USA | 1e595c2a-edd0-43f7-a2db-69553b9557d9 | 2026-01-06 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | f3095db3-fd02-873c-e053-2a95a90a5b1f | 2026-01-01 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | TruPharma, LLC | 7d441128-45d2-4bf2-817b-665784992e90 | 2025-12-29 | Warnings, Adverse reactions | XX73205DH5 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | 464bf611-4dbb-4707-b9dd-39ca178ed4bf | 2025-12-26 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Redpharm Drug | 3251e156-4c52-63b3-e063-6294a90a9a95 | 2025-12-18 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvKARE | c019bf24-8273-8d2f-e053-2a95a90aec98 | 2025-12-03 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvPAK | e78ef7d4-faa7-aebf-e053-2995a90a6f84 | 2025-12-03 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Torrent Pharmaceuticals Limited | dc361b46-fda4-4b0b-9950-e8885ba5b084 | 2025-08-21 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Mylan Institutional Inc. | 989ca8a8-3ad6-4ee4-aa9c-eed731828753 | 2025-07-22 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Kesin Pharma Corporation | 36d940f2-207b-68c5-e063-6294a90a6b4a | 2025-07-01 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NCS HealthCare of KY, LLC dba Vangard Labs | d67dcaad-56c1-4e77-a0c8-655970808414 | 2025-06-13 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a73010fb-960c-4567-8ab1-6d902fee2c14 | 2025-06-02 | Adverse reactions | 314234 XX73205DH5 |
| Sucralfate | SUCRALFATE | ATLANTIC BIOLOGICALS CORP. | e5073597-ac51-4e7c-a9dc-7695773a01f1 | 2025-05-27 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | Richmond Pharmaceuticals, Inc. | 7ac10c3f-9d50-4702-900c-41075ac6f896 | 2025-05-23 | Warnings, Adverse reactions | XX73205DH5 |
| sucralfate | SUCRALFATE | Bryant Ranch Prepack | abc44549-ac41-4aef-9b15-2ba536e1555f | 2025-05-09 | Warnings, Adverse reactions | XX73205DH5 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals, Inc. | 31a7dcd0-e677-249a-e063-6294a90a75f6 | 2025-03-19 | Adverse reactions | 314234 XX73205DH5 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.